ID   TPIS_HUMAN              Reviewed;         286 AA.
AC   P60174; B7Z5D8; D3DUS9; P00938; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   26-FEB-2020, entry version 181.
DE   RecName: Full=Triosephosphate isomerase {ECO:0000305|PubMed:18562316};
DE            Short=TIM;
DE            EC=5.3.1.1 {ECO:0000269|PubMed:18562316};
DE   AltName: Full=Methylglyoxal synthase {ECO:0000250|UniProtKB:P00939};
DE            EC=4.2.3.3 {ECO:0000250|UniProtKB:P00939};
DE   AltName: Full=Triose-phosphate isomerase;
GN   Name=TPI1; Synonyms=TPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2579079;
RA   Maquat L.E., Chilcote R., Ryan P.M.;
RT   "Human triosephosphate isomerase cDNA and protein structure. Studies of
RT   triosephosphate isomerase deficiency in man.";
RL   J. Biol. Chem. 260:3748-3753(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=4022011; DOI=10.1128/mcb.5.7.1694;
RA   Brown J.R., Daar I.O., Krug J.R., Maquat L.E.;
RT   "Characterization of the functional gene and several processed pseudogenes
RT   in the human triosephosphate isomerase gene family.";
RL   Mol. Cell. Biol. 5:1694-1706(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8723724; DOI=10.1101/gr.6.4.314;
RA   Ansari-Lari M.A., Muzny D.M., Lu J., Lu F., Lilley C.E., Spanos S.,
RA   Malley T., Gibbs R.A.;
RT   "A gene-rich cluster between the CD4 and triosephosphate isomerase genes at
RT   human chromosome 12p13.";
RL   Genome Res. 6:314-326(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 27-286 (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-42.
RX   PubMed=2925688;
RA   Boyer T.G., Krug J.R., Maquat L.E.;
RT   "Transcriptional regulatory sequences of the housekeeping gene for human
RT   triosephosphate isomerase.";
RL   J. Biol. Chem. 264:5177-5187(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-286 (ISOFORM 1).
RC   TISSUE=Brain, Kidney, Placenta, Prostate, Skeletal muscle, Skin, and
RC   Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 38-286 (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 39-286.
RX   PubMed=6434534;
RA   Lu H.S., Yuan P.M., Gracy R.W.;
RT   "Primary structure of human triosephosphate isomerase.";
RL   J. Biol. Chem. 259:11958-11968(1984).
RN   [12]
RP   PROTEIN SEQUENCE OF 39-57.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E., Simpson R.J.,
RA   Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed lineage
RT   kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [13]
RP   PROTEIN SEQUENCE OF 39-57.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [14]
RP   PROTEIN SEQUENCE OF 43-51; 56-90; 97-168; 180-193; 198-212 AND 232-256, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.m700120-mcp200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J.,
RA   Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate reductase
RT   M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal
RT   transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51; LYS-231 AND LYS-275, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-117 AND SER-249, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-249; THR-251 AND
RP   SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-231, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 39-286 IN COMPLEX WITH SUBSTRATE
RP   ANALOG, HOMODIMERIZATION, ACTIVE SITE, AND SUBSTRATE BINDING-SITE.
RX   PubMed=8061610; DOI=10.1002/pro.5560030510;
RA   Mande S.C., Mainfroid V., Kalk K.H., Goraj K., Martial J.A., Hol W.G.J.;
RT   "Crystal structure of recombinant human triosephosphate isomerase at 2.8-A
RT   resolution. Triosephosphate isomerase-related human genetic disorders and
RT   comparison with the trypanosomal enzyme.";
RL   Protein Sci. 3:810-821(1994).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 39-286.
RX   PubMed=16511037; DOI=10.1107/s1744309105008341;
RA   Kinoshita T., Maruki R., Warizaya M., Nakajima H., Nishimura S.;
RT   "Structure of a high-resolution crystal form of human triosephosphate
RT   isomerase: improvement of crystals using the gel-tube method.";
RL   Acta Crystallogr. F 61:346-349(2005).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-289 OF MUTANT ASP-142,
RP   FUNCTION, SUBUNIT, CHARACTERIZATION OF VARIANT ASP-142, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=18562316; DOI=10.1074/jbc.m802145200;
RA   Rodriguez-Almazan C., Arreola R., Rodriguez-Larrea D., Aguirre-Lopez B.,
RA   de Gomez-Puyou M.T., Perez-Montfort R., Costas M., Gomez-Puyou A.,
RA   Torres-Larios A.;
RT   "Structural basis of human triosephosphate isomerase deficiency: mutation
RT   E104D is related to alterations of a conserved water network at the dimer
RT   interface.";
RL   J. Biol. Chem. 283:23254-23263(2008).
RN   [36]
RP   VARIANT TPID ASP-142.
RX   PubMed=2876430; DOI=10.1073/pnas.83.20.7903;
RA   Daar I.O., Artymiuk P.J., Phillips D.C., Maquat L.E.;
RT   "Human triose-phosphate isomerase deficiency: a single amino acid
RT   substitution results in a thermolabile enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7903-7907(1986).
RN   [37]
RP   VARIANTS TPID ASP-142 AND MET-269.
RA   Neubauer B.A., Pekrun A., Eber S.W., Lakomek M., Schroeter W.;
RT   "Relation between genetic defect, altered protein structure, and enzyme
RT   function in triose-phosphate isomerase (TPI) deficiency.";
RL   Eur. J. Pediatr. Suppl. 151:232-232(1992).
RN   [38]
RP   VARIANT MANCHESTER ARG-160.
RX   PubMed=1339398; DOI=10.1007/bf02265287;
RA   Perry B.A., Mohrenweiser H.W.;
RT   "Human triosephosphate isomerase: substitution of Arg for Gly at position
RT   122 in a thermolabile electromorph variant, TPI-Manchester.";
RL   Hum. Genet. 88:634-638(1992).
RN   [39]
RP   VARIANT TPID HUNGARY LEU-278.
RX   PubMed=8503454;
RA   Chang M.-L., Artymiuk P.J., Wu X., Hollan S., Lammi A., Maquat L.E.;
RT   "Human triosephosphate isomerase deficiency resulting from mutation of Phe-
RT   240.";
RL   Am. J. Hum. Genet. 52:1260-1269(1993).
RN   [40]
RP   VARIANTS TPID ALA-110; ASP-142 AND MET-192.
RX   PubMed=8571957;
RA   Watanabe M., Zingg B.C., Mohrenweiser H.W.;
RT   "Molecular analysis of a series of alleles in humans with reduced activity
RT   at the triosephosphate isomerase locus.";
RL   Am. J. Hum. Genet. 58:308-316(1996).
RN   [41]
RP   VARIANTS TPID TYR-79; ASP-142 AND VAL-208.
RX   PubMed=9338582;
RX   DOI=10.1002/(sici)1098-1004(1997)10:4<290::aid-humu4>3.0.co;2-l;
RA   Arya R., Lalloz M.R.A., Bellingham A.J., Layton D.M.;
RT   "Evidence for founder effect of the Glu104Asp substitution and
RT   identification of new mutations in triosephosphate isomerase deficiency.";
RL   Hum. Mutat. 10:290-294(1997).
CC   -!- FUNCTION: Triosephosphate isomerase is an extremely efficient metabolic
CC       enzyme that catalyzes the interconversion between dihydroxyacetone
CC       phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis
CC       and gluconeogenesis. {ECO:0000269|PubMed:18562316}.
CC   -!- FUNCTION: It is also responsible for the non-negligible production of
CC       methylglyoxal a reactive cytotoxic side-product that modifies and can
CC       alter proteins, DNA and lipids. {ECO:0000250|UniProtKB:P00939}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate;
CC         Xref=Rhea:RHEA:18585, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776;
CC         EC=5.3.1.1; Evidence={ECO:0000269|PubMed:18562316};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dihydroxyacetone phosphate = methylglyoxal + phosphate;
CC         Xref=Rhea:RHEA:17937, ChEBI:CHEBI:17158, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57642; EC=4.2.3.3;
CC         Evidence={ECO:0000250|UniProtKB:P00939};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.74 mM for D-glyceraldehyde 3-phosphate (at pH 7.4 and 25 degrees
CC         Celsius) {ECO:0000269|PubMed:18562316};
CC         Vmax=7.1 mmol/min/mg enzyme {ECO:0000269|PubMed:18562316};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate from glycerone phosphate: step 1/1. {ECO:0000255|PROSITE-
CC       ProRule:PRU10127}.
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC       {ECO:0000255|PROSITE-ProRule:PRU10127}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|PROSITE-ProRule:PRU10127,
CC       ECO:0000269|PubMed:18562316, ECO:0000269|PubMed:8061610}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=2; IntAct=EBI-717475, EBI-358311;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-717475, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|PROSITE-ProRule:PRU10127}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P60174-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P60174-1; Sequence=VSP_041895;
CC       Name=4;
CC         IsoId=P60174-4; Sequence=VSP_045310;
CC   -!- PTM: The initiator methionine for isoform 2 is removed.
CC   -!- DISEASE: Triosephosphate isomerase deficiency (TPID) [MIM:615512]: An
CC       autosomal recessive multisystem disorder characterized by congenital
CC       hemolytic anemia, progressive neuromuscular dysfunction, susceptibility
CC       to bacterial infection, and cardiomyopathy.
CC       {ECO:0000269|PubMed:2876430, ECO:0000269|PubMed:8503454,
CC       ECO:0000269|PubMed:8571957, ECO:0000269|PubMed:9338582,
CC       ECO:0000269|Ref.37}. Note=The disease is caused by mutations affecting
CC       the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the triosephosphate isomerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51316.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB59511.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH07086.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH07812.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH09329.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH11611.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH15100.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH17917.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH70129.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH70129.1; Type=Miscellaneous discrepancy; Note=Sequence differs at the C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAN86636.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAG36090.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA49379.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Triosephosphate isomerase entry;
CC       URL="https://en.wikipedia.org/wiki/Triosephosphate_isomerase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M10036; AAB59511.1; ALT_INIT; mRNA.
DR   EMBL; X69723; CAA49379.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK298809; BAH12874.1; -; mRNA.
DR   EMBL; U47924; AAB51316.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471116; EAW88722.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88723.1; -; Genomic_DNA.
DR   EMBL; J04603; AAN86636.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; BC007086; AAH07086.1; ALT_INIT; mRNA.
DR   EMBL; BC007812; AAH07812.1; ALT_INIT; mRNA.
DR   EMBL; BC009329; AAH09329.1; ALT_INIT; mRNA.
DR   EMBL; BC011611; AAH11611.1; ALT_INIT; mRNA.
DR   EMBL; BC015100; AAH15100.1; ALT_INIT; mRNA.
DR   EMBL; BC017165; AAH17165.1; -; mRNA.
DR   EMBL; BC017917; AAH17917.1; ALT_INIT; mRNA.
DR   EMBL; BC070129; AAH70129.1; ALT_SEQ; mRNA.
DR   EMBL; AK313282; BAG36090.1; ALT_INIT; mRNA.
DR   EMBL; CR541702; CAG46503.1; -; mRNA.
DR   CCDS; CCDS53740.1; -. [P60174-3]
DR   CCDS; CCDS58206.1; -. [P60174-4]
DR   CCDS; CCDS8566.1; -. [P60174-1]
DR   PIR; S29743; ISHUT.
DR   RefSeq; NP_000356.1; NM_000365.5. [P60174-1]
DR   RefSeq; NP_001152759.1; NM_001159287.1. [P60174-3]
DR   RefSeq; NP_001244955.1; NM_001258026.1. [P60174-4]
DR   PDB; 1HTI; X-ray; 2.80 A; A/B=39-286.
DR   PDB; 1KLG; X-ray; 2.40 A; C=60-74.
DR   PDB; 1KLU; X-ray; 1.93 A; C=60-74.
DR   PDB; 1WYI; X-ray; 2.20 A; A/B=39-286.
DR   PDB; 2IAM; X-ray; 2.80 A; P=60-74.
DR   PDB; 2IAN; X-ray; 2.80 A; C/H/M/R=60-74.
DR   PDB; 2JK2; X-ray; 1.70 A; A/B=39-286.
DR   PDB; 2VOM; X-ray; 1.85 A; A/B/C/D=39-286.
DR   PDB; 4BR1; X-ray; 1.90 A; A/B=41-286.
DR   PDB; 4E41; X-ray; 2.60 A; C/H=60-74.
DR   PDB; 4POC; X-ray; 1.60 A; A/B=38-286.
DR   PDB; 4POD; X-ray; 1.99 A; A/B=38-286.
DR   PDB; 4UNK; X-ray; 2.00 A; A/B=39-286.
DR   PDB; 4UNL; X-ray; 1.50 A; A/B=39-286.
DR   PDB; 4ZVJ; X-ray; 1.70 A; A/B=38-286.
DR   PDB; 6C2G; X-ray; 2.30 A; A/B/C/D=38-286.
DR   PDB; 6D43; X-ray; 2.04 A; A/B=41-286.
DR   PDB; 6NLH; X-ray; 2.20 A; A/B/C/D/E/F/G/H=42-286.
DR   PDBsum; 1HTI; -.
DR   PDBsum; 1KLG; -.
DR   PDBsum; 1KLU; -.
DR   PDBsum; 1WYI; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2JK2; -.
DR   PDBsum; 2VOM; -.
DR   PDBsum; 4BR1; -.
DR   PDBsum; 4E41; -.
DR   PDBsum; 4POC; -.
DR   PDBsum; 4POD; -.
DR   PDBsum; 4UNK; -.
DR   PDBsum; 4UNL; -.
DR   PDBsum; 4ZVJ; -.
DR   PDBsum; 6C2G; -.
DR   PDBsum; 6D43; -.
DR   PDBsum; 6NLH; -.
DR   SMR; P60174; -.
DR   BioGrid; 113020; 117.
DR   IntAct; P60174; 34.
DR   MINT; P60174; -.
DR   STRING; 9606.ENSP00000229270; -.
DR   BindingDB; P60174; -.
DR   ChEMBL; CHEMBL4880; -.
DR   DrugBank; DB04447; 1,4-Dithiothreitol.
DR   DrugBank; DB03379; 2-Carboxyethylphosphonic Acid.
DR   DrugBank; DB03900; 2-Methyl-2-Propanol.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   DrugBank; DB03132; 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid.
DR   DrugBank; DB07387; 3-(BUTYLSULPHONYL)-PROPANOIC ACID.
DR   DrugBank; DB04510; 3-phospho-D-glyceric acid.
DR   DrugBank; DB03314; 5-fluorotryptophan.
DR   DrugBank; DB03135; [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB04326; Dihydroxyacetone phosphate.
DR   DrugBank; DB01695; N-Hydroxy-4-Phosphono-Butanamide.
DR   DrugBank; DB03026; Phosphoglycolohydroxamic Acid.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   MoonProt; P60174; -.
DR   iPTMnet; P60174; -.
DR   PhosphoSitePlus; P60174; -.
DR   SwissPalm; P60174; -.
DR   BioMuta; TPI1; -.
DR   DMDM; 353526311; -.
DR   DOSAC-COBS-2DPAGE; P60174; -.
DR   REPRODUCTION-2DPAGE; IPI00797687; -.
DR   REPRODUCTION-2DPAGE; P60174; -.
DR   SWISS-2DPAGE; P60174; -.
DR   UCD-2DPAGE; P60174; -.
DR   EPD; P60174; -.
DR   jPOST; P60174; -.
DR   MassIVE; P60174; -.
DR   MaxQB; P60174; -.
DR   PaxDb; P60174; -.
DR   PeptideAtlas; P60174; -.
DR   PRIDE; P60174; -.
DR   ProteomicsDB; 57186; -. [P60174-3]
DR   ProteomicsDB; 57187; -. [P60174-1]
DR   ProteomicsDB; 6680; -.
DR   TopDownProteomics; P60174-1; -. [P60174-1]
DR   TopDownProteomics; P60174-3; -. [P60174-3]
DR   TopDownProteomics; P60174-4; -. [P60174-4]
DR   ABCD; P60174; -.
DR   DNASU; 7167; -.
DR   Ensembl; ENST00000229270; ENSP00000229270; ENSG00000111669. [P60174-3]
DR   Ensembl; ENST00000396705; ENSP00000379933; ENSG00000111669. [P60174-1]
DR   Ensembl; ENST00000488464; ENSP00000475620; ENSG00000111669. [P60174-4]
DR   Ensembl; ENST00000535434; ENSP00000443599; ENSG00000111669. [P60174-4]
DR   Ensembl; ENST00000613953; ENSP00000484435; ENSG00000111669. [P60174-3]
DR   GeneID; 7167; -.
DR   KEGG; hsa:7167; -.
DR   UCSC; uc001qrk.5; human. [P60174-3]
DR   CTD; 7167; -.
DR   DisGeNET; 7167; -.
DR   GeneCards; TPI1; -.
DR   HGNC; HGNC:12009; TPI1.
DR   HPA; HPA050924; -.
DR   HPA; HPA053568; -.
DR   MalaCards; TPI1; -.
DR   MIM; 190450; gene.
DR   MIM; 615512; phenotype.
DR   neXtProt; NX_P60174; -.
DR   OpenTargets; ENSG00000111669; -.
DR   Orphanet; 868; Triose phosphate-isomerase deficiency.
DR   PharmGKB; PA36689; -.
DR   eggNOG; KOG1643; Eukaryota.
DR   eggNOG; COG0149; LUCA.
DR   GeneTree; ENSGT00390000013354; -.
DR   HOGENOM; CLU_024251_2_0_1; -.
DR   InParanoid; P60174; -.
DR   KO; K01803; -.
DR   OMA; LCVGEGL; -.
DR   OrthoDB; 540689at2759; -.
DR   PhylomeDB; P60174; -.
DR   TreeFam; TF300829; -.
DR   BioCyc; MetaCyc:HS03441-MONOMER; -.
DR   BRENDA; 5.3.1.1; 2681.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P60174; -.
DR   UniPathway; UPA00109; UER00189.
DR   UniPathway; UPA00138; -.
DR   ChiTaRS; TPI1; human.
DR   EvolutionaryTrace; P60174; -.
DR   GeneWiki; TPI1; -.
DR   GenomeRNAi; 7167; -.
DR   Pharos; P60174; Tbio.
DR   PRO; PR:P60174; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P60174; protein.
DR   Bgee; ENSG00000111669; Expressed in right frontal lobe and 226 other tissues.
DR   ExpressionAtlas; P60174; baseline and differential.
DR   Genevisible; P60174; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0008929; F:methylglyoxal synthase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004807; F:triose-phosphate isomerase activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019563; P:glycerol catabolic process; IBA:GO_Central.
DR   GO; GO:0006096; P:glycolytic process; IBA:GO_Central.
DR   GO; GO:0019242; P:methylglyoxal biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:Ensembl.
DR   CDD; cd00311; TIM; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00147_B; TIM_B; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR035990; TIM_sf.
DR   InterPro; IPR022896; TrioseP_Isoase_bac/euk.
DR   InterPro; IPR000652; Triosephosphate_isomerase.
DR   InterPro; IPR020861; Triosephosphate_isomerase_AS.
DR   PANTHER; PTHR21139; PTHR21139; 1.
DR   Pfam; PF00121; TIM; 1.
DR   SUPFAM; SSF51351; SSF51351; 1.
DR   TIGRFAMs; TIGR00419; tim; 1.
DR   PROSITE; PS00171; TIM_1; 1.
DR   PROSITE; PS51440; TIM_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative promoter usage;
KW   Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Gluconeogenesis; Glycolysis; Hereditary hemolytic anemia;
KW   Isomerase; Isopeptide bond; Lyase; Methylation; Nitration; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN           1..286
FT                   /note="Triosephosphate isomerase"
FT                   /id="PRO_0000090113"
FT   ACT_SITE        133
FT                   /note="Electrophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   ACT_SITE        203
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   BINDING         49
FT                   /note="Substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   BINDING         51
FT                   /note="Substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   MOD_RES         51
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16807684,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17693683,
FT                   ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         105
FT                   /note="Nitrated tyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48500"
FT   MOD_RES         186
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         193
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         210
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         231
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         231
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         231
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         235
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48500"
FT   MOD_RES         246
FT                   /note="Nitrated tyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         251
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         275
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   CROSSLNK        179
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   VAR_SEQ         1..119
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045310"
FT   VAR_SEQ         1..37
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_041895"
FT   VARIANT         79
FT                   /note="C -> Y (in TPID; dbSNP:rs121964848)"
FT                   /evidence="ECO:0000269|PubMed:9338582"
FT                   /id="VAR_007534"
FT   VARIANT         110
FT                   /note="G -> A (in TPID)"
FT                   /evidence="ECO:0000269|PubMed:8571957"
FT                   /id="VAR_007535"
FT   VARIANT         142
FT                   /note="E -> D (in TPID; no effect on triose-phosphate
FT                   isomerase activity; changed protein homodimerization
FT                   activity; the homodimer stability is temperature-dependent
FT                   and affects the triose-phosphate isomerase activity;
FT                   dbSNP:rs121964845)"
FT                   /evidence="ECO:0000269|PubMed:18562316,
FT                   ECO:0000269|PubMed:2876430, ECO:0000269|PubMed:8571957,
FT                   ECO:0000269|PubMed:9338582, ECO:0000269|Ref.37"
FT                   /id="VAR_007536"
FT   VARIANT         160
FT                   /note="G -> R (in Manchester; thermolabile;
FT                   dbSNP:rs121964846)"
FT                   /evidence="ECO:0000269|PubMed:1339398"
FT                   /id="VAR_007537"
FT   VARIANT         192
FT                   /note="V -> M (in TPID; dbSNP:rs188138723)"
FT                   /evidence="ECO:0000269|PubMed:8571957"
FT                   /id="VAR_007538"
FT   VARIANT         208
FT                   /note="I -> V (in TPID; dbSNP:rs121964849)"
FT                   /evidence="ECO:0000269|PubMed:9338582"
FT                   /id="VAR_007539"
FT   VARIANT         269
FT                   /note="V -> M (in TPID)"
FT                   /evidence="ECO:0000269|Ref.37"
FT                   /id="VAR_007540"
FT   VARIANT         278
FT                   /note="F -> L (in TPID; Hungary; thermolabile;
FT                   dbSNP:rs121964847)"
FT                   /evidence="ECO:0000269|PubMed:8503454"
FT                   /id="VAR_007541"
FT   CONFLICT        23..26
FT                   /note="RLRA -> TAR (in Ref. 1; AAB59511)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        36
FT                   /note="Missing (in Ref. 1; AAB59511 and 6; AAN86636)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        57..58
FT                   /note="QS -> KN (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        64
FT                   /note="G -> S (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67..68
FT                   /note="NA -> QG (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80..81
FT                   /note="AP -> IG (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        95
FT                   /note="P -> Q (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        192
FT                   /note="V -> A (in Ref. 9; AAH17917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="P -> N (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        281
FT                   /note="I -> L (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          44..49
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           56..68
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          75..80
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           83..85
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           86..92
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          97..102
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          106..111
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           118..123
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          128..132
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           134..138
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           144..156
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          160..165
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           169..173
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           177..190
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           195..197
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          198..202
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           205..207
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   TURN            208..210
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           216..233
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           236..241
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          244..246
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   TURN            252..254
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           255..260
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   STRAND          266..269
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           271..274
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   HELIX           277..282
FT                   /evidence="ECO:0000244|PDB:4UNL"
FT   TURN            283..285
FT                   /evidence="ECO:0000244|PDB:4UNL"
SQ   SEQUENCE   286 AA;  30791 MW;  E6C2157706AE97F8 CRC64;
     MAEDGEEAEF HFAALYISGQ WPRLRADTDL QRLGSSAMAP SRKFFVGGNW KMNGRKQSLG
     ELIGTLNAAK VPADTEVVCA PPTAYIDFAR QKLDPKIAVA AQNCYKVTNG AFTGEISPGM
     IKDCGATWVV LGHSERRHVF GESDELIGQK VAHALAEGLG VIACIGEKLD EREAGITEKV
     VFEQTKVIAD NVKDWSKVVL AYEPVWAIGT GKTATPQQAQ EVHEKLRGWL KSNVSDAVAQ
     STRIIYGGSV TGATCKELAS QPDVDGFLVG GASLKPEFVD IINAKQ
//
